EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Treatment practices for Helicobacter pylori infection among pediatric gastroenterologists in Latin America

José Fernando Vera Chamorro, Carolina Zambrano Perez, Yessica León Avendaño, Daniela Duarte Montero, Constanza Camargo, Natali Gonzalez Rozo, Ana Karina Coronado, Juan Pablo Riveros, Andres Enriquez, Ailim Margarita Carias, Michelle Higuera, Dianora Navarro, Cesar Moreno, Ericka Montijo‐Barrios, Claudia Liliana Losada, Diego Andrés Blanco, Paul Harris, Luz Arena Martinez, Silvana Bonilla

Journal of Pediatric Gastroenterology and Nutrition · 2026-11-10

DOI: 10.1002/jpn3.70663 ↗
AbstractBibliografische Angaben

Abstract

Abstract Objectives Helicobacter pylori infection remains highly prevalent among children in Latin America, affecting more than 50% of the population. The 2016 pediatric clinical guidelines, adapted to the Latin American context in 2020, were developed to guide treatment practices among pediatric gastroenterologists in the region. However, data on real‐world treatment practices and eradication outcomes remain limited. Therefore, we evaluated the management and outcomes of H. pylori infection among previously untreated, symptomatic pediatric patients managed by practicing pediatric gastroenterologists in Latin America. Methods Multicenter retrospective observational study conducted from 01/2018 to 06/2024 across 48 centers in 9 Latin American countries. Pediatric gastroenterologists reported treatment‐naïve children aged ≤18 years with biopsy‐proven H. pylori infection. Data included sociodemographic, and clinical characteristics, treatment regimens and adherence, and eradication outcomes. Multivariable logistic regression identified factors associated with H. pylori eradication failure. Results Among 488 patients (median age 11 years [range, 1–18]; 51.2% female; 35.6% low socioeconomic status), 20.9% had household H. pylori exposure and 9.1% a family history of gastric cancer. Abdominal pain (86.9%) was the main endoscopy indication; nodular gastropathy (79.9%), erosions (32.9%), and ulcers (6.3%) were common endoscopic findings. Eradication success was 82.8%. Weight‐based dosing was suboptimal, especially in the 25–34 kg category. Family history of gastric cancer was associated with higher failure (odds ratio 2.3, p = 0.019). Conclusion Empiric first‐line therapies’ eradication rate was below the ≥90% target but higher than prior reports from similar settings. Variability in guideline‐recommended, weight‐based dosing highlights opportunities for improvement.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →